Alla studier
RekryteringInterventionell

Evaluation of Quality Improvement for People with Type 2 Diabetes

Called 'EQUIPD2', this study aims to improve care for young adults in England who have Type 2 diabetes. Many young people with this condition have high blood sugar, which can lead to serious health problems. The study wants to find out the best way to help groups of GP practices (called Primary Care Networks or PCNs) to give better care. Researchers will look at three different types of support given to these PCNs to see which is most effective and cost-effective. The findings will help national health bodies decide how to offer support in the future to improve patient care, not just for diabetes but for other conditions too.

Överblick

Status
Rekrytering
Sponsor
Northumbria Universitet
Inskrivningsmål
1,263
Starta
17 Mar 2025
Beräknad slutförande
31 mars 2027

Vad handlar denna studie om?

Type 2 diabetes is a long-term condition that can cause problems if not managed well, especially if blood sugar levels stay high. In England, many young adults with Type 2 diabetes have high blood sugar, which can unfortunately lead to serious health issues and even a shorter lifespan. GP practices play a big role in helping people manage their diabetes, but how well they do this can vary a lot between different areas.

This study, called EQUIPD2, wants to understand the best ways to support these GP practices, specifically those organised into 'Primary Care Networks' (or PCNs). The main goal is to find out if giving PCNs extra help can improve the care they offer to young adults with Type 2 diabetes. They also want to see if the support methods are good value for money for the NHS.

To do this, all PCNs in England will be randomly placed into one of three groups. Each group will receive a different level of support. Researchers will then look at patient information to see if there are improvements in things like blood sugar levels. The results will help the National Diabetes Audit, and other similar national health programmes, decide how best to support healthcare teams across the country to improve the care people receive.

Viktiga punkter

  • This study aims to improve care for young adults with Type 2 diabetes.
  • It's about helping groups of GP practices (PCNs) work better.
  • Patients don't take part directly, but their care could improve.
  • There are no extra risks for patients participating in this study.
  • The results could help improve care for many different health conditions in the future.

Vem kan vara berättigad?

This study is a bit different because it's not looking for individual patients to take part. Instead, it's focusing on entire groups of GP practices, known as Primary Care Networks (PCNs), across England.

So, if you are a patient, you don't need to sign up for this study directly. Your local GP practice, if it's part of a PCN in England, might be involved as a healthcare provider.

No PCNs are being specifically excluded, so all of them in England have a chance to be included in one of the study groups.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Are you a patient seeking medical treatment?
  2. Do you live in England?
  3. Is your GP practice part of a Primary Care Network (PCN)?
  4. Are you a healthcare professional working in a PCN in England?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

This study doesn't involve patients directly. Instead, it focuses on helping groups of GP practices (Primary Care Networks, or PCNs) improve the care they offer. All PCNs in England will be randomly put into one of three groups:

* **Group 1:** Will receive medium-level support, which includes online meetings and special feedback about their performance. * **Group 2:** Will get lower-level support, which involves emails and the same special feedback about their performance. * **Group 3:** Will only receive the special feedback at first, with further support planned for later.

Researchers will then look at existing health information for patients to see if there are improvements in care, such as blood sugar levels. They will also record the online meetings from one of the support groups. As a patient, you won't have any extra appointments, tests, or changes to your medication because of this study. Your medical information will be used in an anonymous way to help the researchers understand if the different types of support for GP practices are working.

Potentiella risker och fördelar

For patients with Type 2 diabetes, there are no extra risks from this study. This is because the study aims to make sure GP practices are following the best recommended advice for patient care. Your care team would receive support to improve their services whether or not they are part of this study. The main benefit is that the study could lead to better ways for GP practices across the country to manage Type 2 diabetes and other conditions, potentially improving care for many people in the future. For healthcare professionals involved, there are also no added risks, and they will receive support that would be available to them anyway. You always have the right to discuss your healthcare with your doctor, and if you have concerns about your data, you can speak to your GP practice.

Platser (1)

  • NHS England
    Ungefärlig
    London, England

Vanliga frågor

What is a 'Primary Care Network' (PCN)?

A PCN is a group of local GP practices that work together to offer better care to their communities.

Will my GP practice know if they are in the study?

Yes, PCNs involved will know which support group they are in.

Will my personal medical information be shared publicly?

No, researchers will use information about patient care and outcomes in a way that protects your privacy and identity, focusing on overall PCN performance rather than individual patient data.

What is 'NDA feedback'?

NDA stands for 'National Diabetes Audit'. It's feedback that helps GP practices understand how well they are doing in treating diabetes compared to others.

Vem betalar för denna studie?

Studien finansieras av National Institute for Health and Care Research (NIHR) i Storbritannien.

Hur du får reda på mer

Michael Sykes

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "Evaluation of Quality Improvement for People with Type 2 Dia…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.